Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;21(11):3178-3193.
doi: 10.1002/tcr.202100059. Epub 2021 May 19.

The Road to Structurally Defined β-Glucans

Affiliations
Review

The Road to Structurally Defined β-Glucans

Patrick Ross et al. Chem Rec. 2021 Nov.

Abstract

β-glucans are polymers of glucose that have been isolated from a variety of organisms. Isolated β-glucans have been used for medical purposes for centuries; however, efforts to define the biological activities of β-glucans experimentally were initiated in the 1940's. The diversity of structure associated with isolated β-glucans has impeded said investigations, and efforts to leverage the biological activity of β-glucans for clinical applications. In recognition of the need for defined β-glucans that retain the biological activity of isolated β-glucans, considerable investment has been made to facilitate the synthesis of structurally defined β-glucans. Here, we review the different approaches that have been applied to prepare β-glucans. In addition, we summarize the approaches that have been utilized to conjugate β-glucans to proteins.

Keywords: carbohydrate chemistry; glycomimetics; polysaccharides; β-glucans.

PubMed Disclaimer

Figures

Scheme 1.
Scheme 1.
Kitamura synthesis of linear β-(1,3)-glucans.
Scheme 2.
Scheme 2.
Takahashi synthesis of linear and branched β-(1,3)-glucans.
Scheme 3.
Scheme 3.
Vetvicka synthesis of β-(1,3)-glucans.
Scheme 4.
Scheme 4.
Bundle synthesis of β-(1,3)-glucans.
Scheme 5.
Scheme 5.
A) Liu and B) Costantino synthesis of β-(1,3)-glucans.
Scheme 6.
Scheme 6.
A) Mechanistic rationalization for ADMB β-selectivity. B) Ensley synthesis of β-(1,3)-glucans.
Scheme 7.
Scheme 7.
Li ionic liquid mediated synthesis of β-(1,3)-glucans.
Scheme 8.
Scheme 8.
Seeberger first generation solid phase synthesis of β-(1,3)-glucans. A) Proof of concept synthesis of β-(1,3)-glucans and B) synthesis of decasaccharide.
Scheme 9.
Scheme 9.
Seeberger second generation solid phase synthesis of β-(1,3)-glucans.
Scheme 10.
Scheme 10.
Enzymatic synthesis of linear β-(1,3)-glucans.
Scheme 11.
Scheme 11.
Enzymatic synthesis of branched β-(1,3)-glucans.
Scheme 12.
Scheme 12.
Bertozzi’s glycopolymer based β-(1,3)-glucan mimetics.
Scheme 13.
Scheme 13.
Carbocycle based β-(1,3)-glucans mimetic. A) hydroxyamine derivatives and B) thioether mimetics of β-(1,3)-glucans.
Scheme 14.
Scheme 14.
Conjugation of β-(1,3)-glucans to proteins via lysine residues
Scheme 15.
Scheme 15.
Protein conjugation of Protein conjugation of β-(1,3)-glucans through lysine residues via tyrosine residues.
Scheme 16.
Scheme 16.
Protein conjugation of naturally isolated laminarin via A) oxidative cleavage and B) reductive amination.

References

    1. Chan GC, Chan WK, Sze DM, J. Hematol. Oncol 2009, 2, 25. - PMC - PubMed
    1. Wang Q, Sheng X, Shi A, Hu H, Yang Y, Liu L, Fei L, Liu H, Molecules 2017, 22, 257. - PMC - PubMed
    1. Pillemer L, Ecker EE, J. Biol. Chem 1941, 137, 139–142;
    2. Legentil L, Paris F, Ballet C, Trouvelot S, Daire X, Vetvicka V, Ferrières V, Molecules 2015, 20, 9745–9766. - PMC - PubMed
    1. Kim HS, Hong JT, Kim Y, Han SB, Immune Netw 2011, 11, 191–195; - PMC - PubMed
    2. Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E, Medicina 2007, 43, 597–606. - PubMed
    1. Sylla B, Guégan JP, Wieruszeski JM, Nugier-Chauvin C, Legentil L, Daniellou R, Ferrières V, Carbohydr. Res 2011, 346, 1490–1494. - PubMed

LinkOut - more resources